Antidepressant drugs are widely prescribed in the United States; however, little is known about their use among major ethnic minority groups. Collaborative Psychiatric Epidemiology Surveys (CPES) data were analyzed to calculate nationally representative estimates of Latino and non-Latino white...

This brief presents noteworthy trends and patterns in the use and costs of prescription drugs for Medicaid beneficiaries from 1999 to 2009. It builds on previous annual tables and chartbooks, and describes trends in drug usage and costs. The brief emphasizes trends for beneficiaries with...

Reports on a survey of eligible entities—including disproportionate share hospitals, federally qualified health centers, community health centers, migrant health centers, and others—on their understanding of the Public Health Service drug pricing program, their decision to...

This article reports on a study that exploits cross-sectional variation on copayment structures among firms with a self-insured retiree health plan to measure the impact of the number of copayment tiers on total and enrollee drug payments, number of prescriptions filled, and generic...

Testimony notes that the Medigap market is not a good source of coverage for prescription drugs, and there are many reasons to expect that it will become much worse. Discusses advantages that Medicare coverage of prescription drugs may offer to policyholders and insurers in the Medigap market.